Edition:
United States

Julie Steenhuysen

U.S. vaccine program chief backs stricter rules for emergency use of COVID-19 shot

Sep 24 2020

CHICAGO The scientific head of the U.S. government program designed to speed development of COVID-19 vaccines said on Thursday he supports stricter rules to grant emergency use of new inoculations against the novel coronavirus.

U.S. vaccine program chief backs stricter rules for emergency use of COVID-19 shot

Sep 24 2020

CHICAGO, Sept 24 The scientific head of the U.S. government program designed to speed development of COVID-19 vaccines said on Thursday he supports stricter rules to grant emergency use of new inoculations against the novel coronavirus.

J&J kicks off study of single-shot COVID-19 vaccine in 60,000 volunteers

Sep 23 2020

CHICAGO Johnson & Johnson on Wednesday began a 60,000-person trial of an experimental single-shot COVID-19 vaccine that, if proven effective, could simplify distribution of millions of doses compared with leading rivals requiring two doses. | Video

J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers

Sep 23 2020

CHICAGO, Sept 23 Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot COVID-19 vaccine that potentially would simplify distribution of millions of doses compared with leading rivals using two doses.

U.S. health agency sets October 16 deadline for states to submit vaccine plans

Sep 22 2020

The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday set an Oct. 16 deadline for states to submit plans for distributing COVID-19 vaccines - even before it becomes clear when any will be available - according to a presentation to a panel of experts who make recommendations on U.S. vaccines.

Moderna to seek limited emergency use of COVID-19 vaccine if data shows high efficacy

Sep 17 2020

CHICAGO If Moderna Inc's COVID-19 vaccine proves to be at least 70% effective, the company plans to seek emergency authorization for its use in high-risk groups, the company's chief executive told Reuters.

Moderna would seek limited emergency use of COVID-19 vaccine based on early data

Sep 17 2020

CHICAGO, Sept 17 If Moderna Inc's COVID-19 vaccine proves to be at least 70 percent effective, the company plans to seek emergency authorization for its use in high-risk groups, the company's chief executive told Reuters.

Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sources

Sep 14 2020

CHICAGO AstraZeneca's COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.

World News